UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 22, 2021
Accession Number:
0001654954-21-004509
Submission Type:
POS AM
CIK:
0000109657
Company Name:
GT Biopharma, Inc.
File Number:
333-251311